{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:01:29Z","timestamp":1791230489465,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.atherosclerosis.2009.02.024","type":"journal-article","created":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T08:14:26Z","timestamp":1236845666000},"page":"148-152","source":"Crossref","is-referenced-by-count":22,"title":["The \u22121131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: A postprandial study"],"prefix":"10.1016","volume":"206","author":[{"given":"Fernando","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Guardiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Queipo-Ortu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mora","family":"Murri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Ribalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Tinahones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.02.024_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1210\/jc.2006-0513","article-title":"Metabolic syndrome: a multiplex cardiovascular risk factor","volume":"92","author":"Grundy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.02.024_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1157\/13079610","article-title":"Determinants of postprandial lipemia measured as diurnal triglyceride profile in non diabetic normolipidemic subjects","volume":"125","author":"Gonz\u00e1lez","year":"2005","journal-title":"Med Clin (Barc)"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2009.02.024_bib3","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/01.ATV.17.11.3041","article-title":"Suppression of lipid transfer inhibitor protein activity by oleate: a novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids","volume":"17","author":"Morton","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2009.02.024_bib4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1194\/jlr.M300350-JLR200","article-title":"Postprandial chylomicrons: potent vehicles for transporting cholesterol from endogenous LDL+HDL and cell membranes to the liver via LCAT and CETP","volume":"45","author":"Chung","year":"2004","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2009.02.024_bib5","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1373\/clinchem.2006.069690","article-title":"Pro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3\/E3 patients with the metabolic syndrome","volume":"52","author":"Cardona","year":"2006","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.02.024_bib6","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1210\/jc.2004-1912","article-title":"The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome","volume":"90","author":"Cardona","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.02.024_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1373\/clinchem.2004.040824","article-title":"The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins","volume":"51","author":"O\u2019Brien","year":"2005","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2009.02.024_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1194\/jlr.M200480-JLR200","article-title":"Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids","volume":"44","author":"Aouizerat","year":"2003","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2009.02.024_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/ATVBAHA.107.144980","article-title":"Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates","volume":"27","author":"Hegele","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2009.02.024_bib10","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2009.02.024_bib11","doi-asserted-by":"crossref","first-page":"17982","DOI":"10.1074\/jbc.M212191200","article-title":"Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators","volume":"278","author":"Vu-Dac","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.02.024_bib12","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Lauer","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.02.024_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2144\/99272bm06","article-title":"Hydrogen peroxide improves the efficiency of a peripheral blood PCR assay for diagnosis of human brucellosis","volume":"27","author":"Queipo-Ortu\u00f1o","year":"1999","journal-title":"Biotechniques"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2009.02.024_bib14","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","article-title":"Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels","volume":"11","author":"Pennacchio","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2009.02.024_bib15","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/11.24.3039","article-title":"Relative contribution of variation within the APOC3\/A4\/A5 gene cluster in determining plasma triglycerides","volume":"11","author":"Talmud","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.02.024_bib16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1253\/circj.71.746","article-title":"Strong linkage disequilibrium and association of \u22121131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population","volume":"71","author":"Matsunaga","year":"2007","journal-title":"Circ J"},{"issue":"31","key":"10.1016\/j.atherosclerosis.2009.02.024_bib17","doi-asserted-by":"crossref","first-page":"28215","DOI":"10.1074\/jbc.M502144200","article-title":"Determination of the functionality of common APOA5 polymorphisms","volume":"280","author":"Talmud","year":"2005","journal-title":"J Biol Chem"},{"issue":"28","key":"10.1016\/j.atherosclerosis.2009.02.024_bib18","doi-asserted-by":"crossref","first-page":"25468","DOI":"10.1074\/jbc.M301302200","article-title":"The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element","volume":"278","author":"Prieur","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2009.02.024_bib19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/ATVBAHA.107.140103","article-title":"Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study","volume":"27","author":"Lai","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.02.024_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2003.06.001","article-title":"Postprandial hyperlipidemia: another correlate of the \u201chypertriglyceridemic waist\u201d phenotype in men","volume":"171","author":"Blackburn","year":"2003","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2009.02.024_bib21","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1210\/jc.2006-1802","article-title":"Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population","volume":"92","author":"Moreno-Luna","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.02.024_bib22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/ajcn\/80.4.832","article-title":"The \u22121131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men","volume":"80","author":"Jang","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.02.024_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1515\/CCLM.2003.078","article-title":"The apolipoprotein AV gene and diurnal triglyceridaemia in normolipidaemic subjects","volume":"41","author":"Masana","year":"2003","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.02.024_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0925-4439(03)00033-4","article-title":"Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges","volume":"1637","author":"Martin","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.02.024_bib25","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/clinchem\/48.9.1597","article-title":"Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia","volume":"48","author":"Ribalta","year":"2002","journal-title":"Clin Chem"},{"issue":"5540","key":"10.1016\/j.atherosclerosis.2009.02.024_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.02.024_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2004.05.003","article-title":"Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5","volume":"319","author":"Fruchart-Najib","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.02.024_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/07853890500407488","article-title":"Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?","volume":"38","author":"Jakel","year":"2006","journal-title":"Ann Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500900149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500900149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T18:32:30Z","timestamp":1589653950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191500900149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S002191500900149X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.02.024","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}